PD pathogenesis
novo PD patients
PD somatic cells
signatures of healthy ageing
healthy ageing trajectories
largest repository of PD patients
therapeutic targets Ageing
gold standard of healthy ageing
framework of ageing process
recent conceptualizations of ageing
prevalent cases of PD discordant twins
centenarians
molecular signatures
large cohorts
molecular perturbations
new molecular profiles
therapy
neuro-inflammaging
informative EXISTING COHORTS
idiopathic Parkinson Disease
idiopathic PARKINSON'S DISEASE
new diagnostic
old twins
propagation phenomena
DISCOVERY PHASE
VALIDATION PHASE
neuronal damage
informative sample
accumulation of senescent cells
identification of druggable targets
propagation perspective of inflammation
integrated set of omics
motor neurodegenerative disorder
innovative neuro-protective therapies
clinical signs of motor disability
major risk factor
early diagnosis
incident
dopaminergic neurons
prognostic
Swedish Twin Registry
search
results
omic data
basic mechanisms
exposure
toxicants
prion
studies
biomaterials
continuum
PPMI
iPSC protocol
added value
main goal of PROPAG
lifestyle
years
approach
project
brains
offspring